TESTA, Maria Francesca
 Distribuzione geografica
Continente #
NA - Nord America 1.319
AS - Asia 1.021
EU - Europa 461
SA - Sud America 140
AF - Africa 31
Totale 2.972
Nazione #
US - Stati Uniti d'America 1.270
SG - Singapore 373
CN - Cina 208
IT - Italia 134
VN - Vietnam 118
BR - Brasile 102
DE - Germania 89
HK - Hong Kong 84
IN - India 51
GB - Regno Unito 47
FI - Finlandia 43
JP - Giappone 36
BD - Bangladesh 35
CA - Canada 27
FR - Francia 26
RU - Federazione Russa 26
ID - Indonesia 25
TR - Turchia 23
IQ - Iraq 16
UA - Ucraina 16
MX - Messico 15
PL - Polonia 15
SE - Svezia 14
AR - Argentina 13
CZ - Repubblica Ceca 11
ZA - Sudafrica 9
PK - Pakistan 8
NL - Olanda 7
VE - Venezuela 7
ES - Italia 6
LT - Lituania 6
MY - Malesia 6
SA - Arabia Saudita 6
DZ - Algeria 5
EC - Ecuador 5
JO - Giordania 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
BO - Bolivia 4
CH - Svizzera 4
CL - Cile 4
AL - Albania 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
MA - Marocco 3
UZ - Uzbekistan 3
BH - Bahrain 2
CO - Colombia 2
CR - Costa Rica 2
ET - Etiopia 2
IE - Irlanda 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
NG - Nigeria 2
NO - Norvegia 2
PA - Panama 2
PH - Filippine 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
AO - Angola 1
BE - Belgio 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KR - Corea 1
MN - Mongolia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
RE - Reunion 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 2.972
Città #
Singapore 230
Ashburn 214
San Jose 147
Santa Clara 84
Hong Kong 82
Beijing 75
Dallas 66
New York 61
Fairfield 50
Los Angeles 50
Chandler 48
Ferrara 41
Munich 40
Council Bluffs 39
Hanoi 37
Tokyo 34
Helsinki 32
Ho Chi Minh City 30
Seattle 26
Houston 25
Jakarta 18
Milan 18
Wilmington 18
Rome 16
Cambridge 15
Orem 15
Warsaw 15
Woodbridge 14
Atlanta 13
London 13
Shanghai 13
São Paulo 12
Lauterbourg 11
Baghdad 10
Montreal 10
Poplar 10
Princeton 10
Chennai 9
Mexico City 9
Brno 8
Chicago 8
Falkenstein 8
Mānsa 8
Naples 8
San Diego 8
Stockholm 8
Toronto 8
Ankara 7
Bremen 7
Frankfurt am Main 7
Jacksonville 7
Mumbai 7
Belo Horizonte 6
Brooklyn 6
Buffalo 6
Denver 6
Florence 6
Izmir 6
Johannesburg 6
Moscow 6
Turku 6
Amman 5
Boardman 5
Da Nang 5
Dearborn 5
Haiphong 5
Hefei 5
Lappeenranta 5
Manchester 5
Phoenix 5
Redwood City 5
Biên Hòa 4
Bologna 4
Delhi 4
Guangzhou 4
Jaipur 4
Nanjing 4
Nuremberg 4
Rochester 4
San Francisco 4
San Mateo 4
St Petersburg 4
The Dalles 4
Baku 3
Bexley 3
Boston 3
Brescello 3
Buenos Aires 3
Campinas 3
Charlotte 3
City of London 3
Curitiba 3
Kunming 3
Kyiv 3
Lahore 3
New Delhi 3
Olomouc 3
Paris 3
Philadelphia 3
Querétaro 3
Totale 1.962
Nome #
TRPP2 dysfunction decreases ATP-evoked calcium, induces cell aggregation and stimulates proliferation in T lymphocytes 187
Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B 184
Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B 180
An engineered factor X variant as a novel by-passing agent for hemophilia 157
Molecular insights into determinants of translational readthrough and implications for nonsense suppression approaches 156
Detection of Residual Factor VIII Levels Reveals the Occurrence of Readthrough Over the Majority of F8 Nonsense Mutations 155
An integrated multi-tool analysis contributes elements to interpreting unclassified factor IX missense variants associated with haemophilia B 152
Comparative Analysis Of Residual Factor VIII Expression from Recurrent F8 Nonsense Mutations Indicates that Localization in the B- domain Favours Readthrough- mediated Protein Output 151
An advanced method for the small-scale production of high-quality minicircle DNA 149
Exploring spontaneous readthrough over recurrent F8 nonsense mutations: potential correlation with inhibitor risk? 148
Translation termination codons in protein synthesis and disease 129
A factor X variant with engineered activation peptide as innovative by-passing agent for haemophilia 128
Spontaneous readthrough over recurrent F8 nonsense mutations is associated with residual factor VIII levels: implications for inhibitor risk? 124
The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms 103
Engineered suppressor tRNAs as a novel correction approach for recurrent hemophilia A-causing nonsense mutations 100
Translational readthrough at F8 nonsense variants in the factor VIII B domain contributes to residual expression and lowers inhibitor association 95
Design of an engineered coagulation factor X as a novel by-passing agent for hemophilia 88
Base and Prime Editors as new correction approaches for recurrent Hemophilia A Nonsense Mutations 87
Tailored collagen binding confers distinct functional properties to engineered factor IX fusion proteins in hemophilia B mouse model 87
A novel tailored correction approach for recurrent hemophilia-causing nonsense mutations through AntiCodon-Engineered suppressor tRNAs 85
Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional properties 83
Reverting highly frequent f8 nonsense mutations: base and prime editing approach for hemophilia A 77
The heterozygous p.R854Q variant is responsible for the conformational changes in the D’D3 domain of the von Willebrand Factor, by weakening its interaction with factor VIII: in-silico analysis 72
Engineered tRNAs as a novel tailored correction approach to restore protein biosynthesis and function from hemophilia-causing nonsense mutations 72
Novel Genetic Classification of Inhibitor Risk for F8 Nonsense Mutations Based on Immunogenic Profiling of Ribosomal Readthrough in EAHAD Database 56
Von Willebrand factor natural variants of the arginine 1205: in-silico analysis of the protein structural changes and its interactions with the macrophagic scavenger receptor LRP1 31
Rational design of a novel engineered factor X with chimeric activation peptide as bypassing agent for haemophilia 6
Totale 3.042
Categoria #
all - tutte 13.612
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 651
Totale 14.263


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/202280 17 7 1 6 1 3 1 2 4 7 3 28
2022/2023115 11 14 5 9 16 8 11 11 14 2 4 10
2023/2024128 6 6 7 1 4 33 4 10 10 4 5 38
2024/2025626 23 8 47 16 58 112 15 30 75 65 97 80
2025/20261.872 208 80 103 251 278 130 241 85 171 194 125 6
Totale 3.042